- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT05743153
Genomförbarhet av ett multimodalt interventionsprogram för att optimera behandlingsresultat vid ulcerös kolit (OPTIMIZE-UC)
OPTIMIZE-UC: Genomförbarhet av ett multimodalt interventionsprogram för att optimera behandlingsresultat vid ulcerös kolit: en prospektiv pilotstudie
This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active disease as well as in patients in remission. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Rationale: Despite considerable advances in the knowledge of UC, and a variation of treatment options, UC still impacts patients' ability to lead a normal life. Clearly, there is an unmet need to improve treatment outcomes. Prehabilitation programs in surgery have shown that the amount of complications is closely related to preoperative physical fitness, nutritional status and psychological well-being. IBD patients often search for self-management strategies to manage their symptoms, however, research focussing on a multimodal intervention approach in parallel to starting new IBD treatment is lacking. Given the potential benefits of intervention programs, limitations of current treatments in terms of improving quality of life and patients' desire for self-management options, we believe that exploring the results of a multimodal intervention program in patients with UC is of high relevance.
Objective/study design: This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in UC patients. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Study population: Patients ≥ 18 years old, with UC. Intervention: Multimodal intervention program including an exercise program, nutritional intervention and psychological evaluation.
Main study parameters/endpoints: This study assesses the feasibility of a multimodal intervention program. Secondary, assesses the effect on:
- Individual patients' level, i.e. physical fitness, nutritional status, mental health, quality of life and work productivity and activity impairment.
- Therapy outcomes, e.g. adherence, number and severity of (S)AEs, corticosteroid use, biochemical and clinical response/remission rates and patient reported outcomes.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Nijmegen, Nederländerna, 6525GA
- Dorien Oomkens
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Age ≥ 18 years old;
- Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria;
- Ability of subject to participate fully in all aspects of this project;
- Written informed consent must be obtained and documented.
Exclusion Criteria:
- Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis;
- Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder);
- History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures;
- If female, the subject is pregnant or lactating (< 1 year) or intending to become pregnant;
- Immobilized patients who are not able to complete exercise intervention;
- Illiteracy (disability to read and understand Dutch).
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Patients with ulcerative colitis
Patients participate in multimodal intervention |
Exercise intervention: combined endurance and resistance training three times a week using workout video's which patients can do at home. Advice to exercise at low-intensity for at least 30 minutes per day. Nutritional intervention: Patients are advised to aim for optimal energy and protein intake (by registered dietician) and to avoid red meat, processed foods and sweetened drinks. Aiming for a mainly plant based diet. Psychological intervention: screening for psychological risk factors and if present, patients are referred to a psychologist for psychological support. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Accrural
Tidsram: 24 weeks
|
The percentage of approached, eligible participants that are included in the study. |
24 weeks
|
|
Attrition
Tidsram: 24 weeks
|
The percentage of participants who stopped the program prematurely. |
24 weeks
|
|
Adherence to exercise program
Tidsram: 24 weeks
|
Frequency of followed trainings |
24 weeks
|
|
Adherence to daily exercise goals
Tidsram: 24 weeks
|
SQUASH questionnaire |
24 weeks
|
|
Patient satisfaction
Tidsram: 24 weeks
|
Measured using a patient satisfaction questionnaire |
24 weeks
|
|
Safety and adverse events
Tidsram: 24 weeks
|
Measured by the number of adverse events occurring during the program |
24 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in Oxygen Consumption (VO2 max)
Tidsram: 1 year
|
Indication of physical fitness |
1 year
|
|
Change in 1 repitition measures
Tidsram: 1 year
|
Indication of muscle strength |
1 year
|
|
Change in body weight
Tidsram: 1 year
|
Measured in kilograms |
1 year
|
|
Change in fat-free mass
Tidsram: 1 year
|
Measured with bioelectrical impedance analysis (BIA) |
1 year
|
|
Change in nutritional status
Tidsram: 1 year
|
Measured with Patient Generated Subjective Global Assessment (PG-SGA) |
1 year
|
|
Change in mental health
Tidsram: 1 year
|
Hospital Anxiety and Depression scale (HADS questionnaire) |
1 year
|
|
Change in Work Productivity and Activity Impairment
Tidsram: 1 year
|
Work Productivity and Activity Impairment Questionnaire (including WPAI-GH) |
1 year
|
|
Change in 36-Item Short Form Health Survey (SF-36) score
Tidsram: 1 year
|
Quality of life |
1 year
|
|
Change in EuroQoL (EQ-5D-5L) score
Tidsram: 1 year
|
Quality of life |
1 year
|
|
Change in Inflammatory Bowel Disease Questionnaire score
Tidsram: 1 year
|
Disease-related quality of life |
1 year
|
Samarbetspartners och utredare
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 114110
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .